Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis. Torres S, Ortiz C, Bachtler N, Gu W, et al. Hepatology 2023;77:1228-1240.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Torres S, Ortiz C, Bachtler N, Gu W, et al. Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis. Hepatology 2023;77:1228-1240.
PMID: 35993369